569 related articles for article (PubMed ID: 16441215)
1. Pharmacological advances in the treatment of invasive candidiasis.
Deck DH; Guglielmo BJ
Expert Rev Anti Infect Ther; 2006 Feb; 4(1):137-49. PubMed ID: 16441215
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in antifungal chemotherapy.
Petrikkos G; Skiada A
Int J Antimicrob Agents; 2007 Aug; 30(2):108-17. PubMed ID: 17524625
[TBL] [Abstract][Full Text] [Related]
3. Emergence of Candida albicans fungemia during voriconazole therapy.
Mohammedi I; Thiebaut A; Piens MA; Argaud L; Martin O; Robert D
J Infect; 2005 Oct; 51(3):e83-4. PubMed ID: 16230209
[No Abstract] [Full Text] [Related]
4. Optimizing therapy for Candida infections.
Playford EG; Sorrell TC
Semin Respir Crit Care Med; 2007 Dec; 28(6):678-88. PubMed ID: 18095232
[TBL] [Abstract][Full Text] [Related]
5. A global evaluation of voriconazole activity tested against recent clinical isolates of Candida spp.
Diekema DJ; Messer SA; Hollis RJ; Boyken L; Tendolkar S; Kroeger J; Jones RN; Pfaller MA
Diagn Microbiol Infect Dis; 2009 Feb; 63(2):233-6. PubMed ID: 19070452
[TBL] [Abstract][Full Text] [Related]
6. Candida resistance and its clinical relevance.
Klepser ME
Pharmacotherapy; 2006 Jun; 26(6 Pt 2):68S-75S. PubMed ID: 16716125
[TBL] [Abstract][Full Text] [Related]
7. Triazole cross-resistance among Candida spp.: case report, occurrence among bloodstream isolates, and implications for antifungal therapy.
Magill SS; Shields C; Sears CL; Choti M; Merz WG
J Clin Microbiol; 2006 Feb; 44(2):529-35. PubMed ID: 16455909
[TBL] [Abstract][Full Text] [Related]
8. Combination antifungals: an update.
Segal BH; Steinbach WJ
Expert Rev Anti Infect Ther; 2007 Oct; 5(5):883-92. PubMed ID: 17914921
[TBL] [Abstract][Full Text] [Related]
9. Antifungals in the ICU.
Playford EG; Eggimann P; Calandra T
Curr Opin Infect Dis; 2008 Dec; 21(6):610-9. PubMed ID: 18978529
[TBL] [Abstract][Full Text] [Related]
10. Recent experience with fungaemia: change in species distribution and azole resistance.
Chakrabarti A; Chatterjee SS; Rao KL; Zameer MM; Shivaprakash MR; Singhi S; Singh R; Varma SC
Scand J Infect Dis; 2009; 41(4):275-84. PubMed ID: 19229762
[TBL] [Abstract][Full Text] [Related]
11. Triazole-resistant candidaemia following posaconazole exposure.
Weiler S; Lass-Flörl C; Auberger J; Bellmann-Weiler R; Stein M; Joannidis M; Bellmann R
Int J Antimicrob Agents; 2009 May; 33(5):494-5. PubMed ID: 19153033
[No Abstract] [Full Text] [Related]
12. Epidemiology and antifungal susceptibilities of Candida spp. to six antifungal agents: results from a surveillance study on fungaemia in Germany from July 2004 to August 2005.
Borg-von Zepelin M; Kunz L; Rüchel R; Reichard U; Weig M; Gross U
J Antimicrob Chemother; 2007 Aug; 60(2):424-8. PubMed ID: 17562683
[TBL] [Abstract][Full Text] [Related]
13. [Echinocandins in invasive candidiasis].
Glöckner A; Cornely OA
Med Klin (Munich); 2008 Jun; 103(6):397-405. PubMed ID: 18548209
[TBL] [Abstract][Full Text] [Related]
14. The fluconazole era: management of hematogenously disseminated candidiasis in the nonneutropenic patient.
Kramer KM; Skaar DJ; Ackerman BH
Pharmacotherapy; 1997; 17(3):538-48. PubMed ID: 9165556
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility of Candida species isolated from immunocompromised patients to antifungal agents.
Badiee P; Alborzi A; Shakiba E; Farshad S; Japoni A
East Mediterr Health J; 2011 May; 17(5):425-30. PubMed ID: 21796956
[TBL] [Abstract][Full Text] [Related]
16. Antifungal susceptibility of 1000 Candida bloodstream isolates to 5 antifungal drugs: results of a multicenter study conducted in São Paulo, Brazil, 1995-2003.
da Matta DA; de Almeida LP; Machado AM; Azevedo AC; Kusano EJ; Travassos NF; Salomão R; Colombo AL
Diagn Microbiol Infect Dis; 2007 Apr; 57(4):399-404. PubMed ID: 17240110
[TBL] [Abstract][Full Text] [Related]
17. New antifungal agents for the treatment of candidaemia.
Muñoz P; Guinea J; Rojas L; Bouza E
Int J Antimicrob Agents; 2010 Dec; 36 Suppl 2():S63-9. PubMed ID: 21129925
[TBL] [Abstract][Full Text] [Related]
18. [Epidemiological study of invasive nosocomial candidiasis in 2 teaching hospitals in Beijing].
Cao B; Wang H; Wu L; Sun WJ; Li F; Liu YM
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1970-3. PubMed ID: 19062737
[TBL] [Abstract][Full Text] [Related]
19. Antifungal resistance in pathogenic fungi.
Perea S; Patterson TF
Clin Infect Dis; 2002 Nov; 35(9):1073-80. PubMed ID: 12384841
[TBL] [Abstract][Full Text] [Related]
20. Candidaemia with uncommon Candida species: predisposing factors, outcome, antifungal susceptibility, and implications for management.
Chen SC; Marriott D; Playford EG; Nguyen Q; Ellis D; Meyer W; Sorrell TC; Slavin M;
Clin Microbiol Infect; 2009 Jul; 15(7):662-9. PubMed ID: 19614718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]